Immutep targets $100m for lung cancer drug trial tests
Immutep has launched a capital raise aiming to boost its war chest by $100 million to progress late stage trials for lung cancer sufferers.
Corporate Spotlight
Not Yet Available
Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.
Latest Threads
Tag | Subject | ||||||
---|---|---|---|---|---|---|---|
DRN | my great tip for next year | 29/12/06 | 0 | 905 | |||
|
|||||||
DRN | captial restruture | 25/11/06 | 2 | 1.3K | |||
|
|||||||
DRN | buyers about | 07/10/06 | 0 | 415 | |||
|
|||||||
DRN | guanaco programme update | 06/06/06 | 5 | 1.7K | |||
|
|||||||
DRN | someone is desperate to buy | 30/05/06 | 11 | 3.0K | |||
|
|||||||
DRN | has been a beauty | 25/05/06 | 1 | 668 | |||
|
|||||||
DRN | nice move today /anyone listen | 23/04/06 | 5 | 2.0K | |||
|
|||||||
DRN | a little gold sleeper | 08/03/06 | 6 | 1.8K | |||
|
See All Discussions